Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation

被引:0
|
作者
Zhenfeng Guan
Yi Sun
Liang Mu
Yazhuo Jiang
Jinhai Fan
机构
[1] Shaanxi Provincial People’s Hospital,Department of Urology
[2] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Urology
[3] Shaanxi Provincial People’s Hospital,Department of B ultrasound
来源
BMC Cancer | / 22卷
关键词
Bladder cancer; Tenascin-C; Syndecan-4; progression; NF-κB;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
    Zhuo, Changhua
    Ruan, Qiang
    Zhao, Xiangqian
    Shen, Yangkun
    Lin, Ruirong
    BIOLOGY DIRECT, 2022, 17 (01)
  • [22] CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
    Changhua Zhuo
    Qiang Ruan
    Xiangqian Zhao
    Yangkun Shen
    Ruirong Lin
    Biology Direct, 17
  • [23] The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
    Maosheng Cheng
    Lu Sheng
    Qian Gao
    Qiuchan Xiong
    Haojie Zhang
    Mingqing Wu
    Yu Liang
    Fengyu Zhu
    Yingyin Zhang
    Xiuhong Zhang
    Quan Yuan
    Yang Li
    Oncogene, 2019, 38 : 3667 - 3680
  • [24] The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
    Cheng, Maosheng
    Sheng, Lu
    Gao, Qian
    Xiong, Qiuchan
    Zhang, Haojie
    Wu, Mingqing
    Liang, Yu
    Zhu, Fengyu
    Zhang, Yingyin
    Zhang, Xiuhong
    Yuan, Quan
    Li, Yang
    ONCOGENE, 2019, 38 (19) : 3667 - 3680
  • [25] Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling
    Jiang, Lili
    Ren, Liangliang
    Zhang, Xiaolan
    Chen, Han
    Chen, Xuhong
    Lin, Chun
    Wang, Lan
    Hou, Ning
    Pan, Jinyuan
    Zhou, Zhongqiu
    Huang, Hongbiao
    Huang, Danping
    Yang, Jianan
    Liang, Yingying
    Li, Jun
    EBIOMEDICINE, 2019, 43 : 188 - 200
  • [26] Neuronatin Promotes the Progression of Non-Small Cell Lung Cancer by Activating the NF-κB Signaling
    Xiong, Huanwen
    Chen, Guohua
    Fang, Ke
    Gu, Weiguo
    Qiu, Feng
    CURRENT CANCER DRUG TARGETS, 2024, 24 (11) : 1128 - 1143
  • [27] SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway
    Huang, Da
    Zeng, Ying
    Deng, Han-Yue
    Fu, Bi-Dong
    Ke, Yun
    Luo, Jing-Yi
    Yu, Ji-Chun
    Yu, Shi-Tong
    ENDOCRINOLOGY, 2022, 164 (01)
  • [28] UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
    Long, Li
    Wang, Lei
    Liang, Yiran
    Ye, Fangzhou
    Jin, Yuhan
    Luo, Dan
    Li, Xiaoyan
    Wang, Yajie
    Li, Yaming
    Han, Dianwen
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Yang, Qifeng
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [29] TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling
    Tan, Shu-Tao
    Liu, Sheng-Ye
    Wu, Bin
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1302 - 1312
  • [30] Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling
    Liu, Jia
    Gong, Xue
    Zhu, Xingwang
    Xue, Dongwei
    Liu, Yili
    Wang, Ping
    ONCOTARGET, 2017, 8 (43) : 75272 - 75283